Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6286 to 6300 of 8908 results

  1. Further research should be in the form of randomised controlled trials or registries. It should report:

    Recommendation ID IPG778 Question Further research should be in the form of randomised controlled trials or registries. It should report:

    Research recommendation
    Published
    11 January 2024

  2. What interventions are effective and cost effective in supporting return to work after recurrent short-term sickness absence in the UK?

    Recommendation ID NG146/2 Question What interventions are effective and cost effective in supporting return to work after recurrent short-term

    Research recommendation
    Published
    10 February 2020

  3. For people with common mental health conditions, what interventions are effective and cost effective in reducing long-term sickness absence and supporting return to work in the UK?

    Recommendation ID NG146/3 Question For people with common mental health conditions, what interventions are effective and cost effective

    Research recommendation
    Published
    10 February 2020

  4. What interventions are effective and cost effective in supporting return to work, in all workplaces including micro-, small- and medium-sized organisations, after long-term sickness absence in the UK?

    Recommendation ID NG146/1 Question What interventions are effective and cost effective in supporting return to work, in all workplaces

    Research recommendation
    Published
    10 February 2020

  5. Intermittent urinary catheters: catheter selection:- For patients performing intermittent self-catheterisation over the long term, what is the clinical and cost effectiveness of single-use non-coated versus single-use hydrophilic versus single-use gel reservoir versus reusable non-coated catheters with regard to the following outcomes: symptomatic urinary tract infections, urinary tract infection-associated bacteraemia, mortality, patient comfort and preference, quality of life, and clinical symptoms of urethral damage?

    Recommendation ID CG139/3 Question Intermittent urinary catheters: catheter selection:- For patients performing intermittent self-catheterisation

    Research recommendation
    Published
    9 June 2015

  6. Novel endovascular interventions: What is the clinical and cost effectiveness of novel endovascular techniques and devices such as coated coils, endoluminal flow diverters and intrasaccular devices to treat aneurysmal subarachnoid haemorrhage?

    Recommendation ID NG228/04 Question Novel endovascular interventions: What is the clinical and cost effectiveness of novel endovascular

    Research recommendation
    Published
    12 December 2022

  7. Follow-up strategies: What is the clinical and cost effectiveness of patient-initiated follow-up compared with routine follow-up for people with osteoarthritis?

    Recommendation ID NG226/04 Question Follow-up strategies: What is the clinical and cost effectiveness of patient-initiated follow-up compared

    Research recommendation
    Published
    7 November 2022

  8. Oxygen therapy for OSAHS: What is the clinical and cost effectiveness of nocturnal oxygen compared with placebo in people with OSAHS who are unable to tolerate CPAP?

    Recommendation ID NG202/9 Question Oxygen therapy for OSAHS: What is the clinical and cost effectiveness of nocturnal oxygen compared with

    Research recommendation
    Published
    30 September 2021

  9. What is the clinical and cost effectiveness of omega-3 fatty acids in the treatment of children and young people considered to be at high risk of developing psychosis?

    Recommendation ID CG155/2 Question What is the clinical and cost effectiveness of omega-3 fatty acids in the treatment of children and

    Research recommendation
    Published
    9 June 2015

  10. Core outcomes for study reporting: Which mental wellbeing and productivity outcomes should be used in a core outcome set for research into workplace mental wellbeing?

    Recommendation ID NG212/05 Question Core outcomes for study reporting: Which mental wellbeing and productivity outcomes should be used

    Research recommendation
    Published
    8 April 2022

  11. Risk of systemic anticancer treatment in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are receiving/have recently received systemic anticancer treatment (SACT) (that is, within the 4 weeks preceding a diagnosis of COVID-19) at increased risk of severe COVID-19 illness or death?

    Recommendation ID NG161/1 Question Risk of systemic anticancer treatment in people with cancer and COVID-19: Are patients with cancer and

    Research recommendation
    Published
    21 October 2021

  12. Risk of radiotherapy in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are receiving/have recently received radiotherapy (that is, within the 4 weeks preceding a diagnosis of COVID-19) at increased risk of severe COVID-19 illness or death?

    Recommendation ID NG162/1 Question Risk of radiotherapy in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are

    Research recommendation
    Published
    21 October 2021

  13. Opt-out strategies for front-line health and social care staff:- Are opt-out strategies effective and cost effective at increasing uptake of flu vaccination among front-line health and social care staff?

    Recommendation ID NG103/4 Question Opt-out strategies for front-line health and social care staff:- Are opt-out strategies effective and

    Research recommendation
    Published
    12 December 2018

  14. Second-generation endometrial ablation for HMB associated with myometrial pathology:- Are outcomes after second-generation endometrial ablation for women with HMB associated with myometrial pathology (adenomyosis and/or uterine fibroids) equivalent to those for women without myometrial pathology?

    Recommendation ID NG88/5 Question Second-generation endometrial ablation for HMB associated with myometrial pathology:- Are outcomes after

    Research recommendation
    Published
    14 November 2018

  15. Signs and symptoms of Kawasaki disease: Which signs and symptoms (or combinations of signs and symptoms) predict a diagnosis of Kawasaki disease in children under 5 presenting with fever lasting 5 days or more?

    Recommendation ID NG143/08 Question Signs and symptoms of Kawasaki disease: Which signs and symptoms (or combinations of signs and symptoms)

    Research recommendation
    Published
    17 December 2021